These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20634043)

  • 1. Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia.
    Bresee LC; Majumdar SR; Patten SB; Johnson JA
    Eur Psychiatry; 2011; 26(5):327-32. PubMed ID: 20634043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.
    Bresee LC; Majumdar SR; Patten SB; Johnson JA
    Schizophr Res; 2010 Mar; 117(1):75-82. PubMed ID: 20080392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study.
    Chiu M; Rahman F; Vigod S; Wilton AS; Kurdyak P
    J Epidemiol Community Health; 2018 Jan; 72(1):71-77. PubMed ID: 29061843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of general and specialized cardiac care by people with schizophrenia.
    Bresee LC; Majumdar SR; Patten SB; Johnson JA
    Psychiatr Serv; 2012 Mar; 63(3):237-42. PubMed ID: 22307876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area.
    Bernardo M; Cañas F; Banegas JR; Casademont J; Riesgo Y; Varela C;
    Eur Psychiatry; 2009 Oct; 24(7):431-41. PubMed ID: 19783126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common familial risk factors for schizophrenia and diabetes mellitus.
    Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
    Aust N Z J Psychiatry; 2016 May; 50(5):488-94. PubMed ID: 26209325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
    Grover SA; Lowensteyn I; Kaouache M; Marchand S; Coupal L; DeCarolis E; Zoccoli J; Defoy I
    Arch Intern Med; 2006 Jan; 166(2):213-9. PubMed ID: 16432091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male erectile dysfunction and cardiovascular disease: is there an intimate nexus?
    Chew KK; Bremner A; Jamrozik K; Earle C; Stuckey B
    J Sex Med; 2008 Apr; 5(4):928-934. PubMed ID: 18194189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease and spinal cord injury: results from a national population health survey.
    Cragg JJ; Noonan VK; Krassioukov A; Borisoff J
    Neurology; 2013 Aug; 81(8):723-8. PubMed ID: 23884034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and chronic disease.
    Rao DP; Dai S; Lagacé C; Krewski D
    Chronic Dis Inj Can; 2014 Feb; 34(1):36-45. PubMed ID: 24618380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study.
    Abu-Ashour W; Chibrikova L; Midodzi WK; Twells LK; Gamble JM
    Diabet Med; 2017 Feb; 34(2):229-234. PubMed ID: 26802577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada.
    Curkendall SM; Mo J; Glasser DB; Rose Stang M; Jones JK
    J Clin Psychiatry; 2004 May; 65(5):715-20. PubMed ID: 15163261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Reed ML; Kurth T; Fanning KM; Buse DC
    Headache; 2017 Nov; 57(10):1507-1521. PubMed ID: 28990165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain].
    Ortega E; Amor AJ; Rojo-Martínez G; Castell C; Giménez M; Conget I
    Med Clin (Barc); 2015 Sep; 145(6):233-8. PubMed ID: 25561182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent and determinants of diabetes and cardiovascular disease comorbidity in South Africa - results from the South African National Health and Nutrition Examination Survey (SANHANES-1).
    Mutyambizi C; Chola L; Groot W; Pavlova M; Labadarios D; Hongoro C
    BMC Public Health; 2017 Sep; 17(1):745. PubMed ID: 28950847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care and management of cardiovascular risk factors among individuals with schizophrenia and type 2 diabetes who smoke.
    Himelhoch S; Leith J; Goldberg R; Kreyenbuhl J; Medoff D; Dixon L
    Gen Hosp Psychiatry; 2009; 31(1):30-2. PubMed ID: 19134507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and type 2 diabetes mellitus.
    Mamakou V; Thanopoulou A; Gonidakis F; Tentolouris N; Kontaxakis V
    Psychiatriki; 2018; 29(1):64-73. PubMed ID: 29754122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.